TAVALISSE

medison pharma canada inc.🇨🇦 Health Canada

Approval Id: f85cd1665e308b1c
Drug Approval Canada Name: TAVALISSE
Product Name: TAVALISSE
Status: Marketed
Status Date: 2022-07-04
Original Market Date: 2020-12-10
Din: 02508060
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 20:28.16
Atc Original: B02BX09 FOSTAMATINIB
Atc Name: b 02 bx 09
Aig Number: 0162598001
Company Name: medison pharma canada inc.
Company Address: 400-154 University Avenue, Toronto, Ontario, Canada, M5H 3Y9

FOSTAMATINIB (FOSTAMATINIB DISODIUM)

150 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f85cd1665e308b1c

Type

Standard